Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) is now available.
China Resources Pharmaceutical Group Ltd. has announced its upcoming annual general meeting scheduled for May 23, 2025, where shareholders will consider the audited financial statements, declare a final dividend, and re-elect directors. The meeting will also address the re-appointment of KPMG as auditors and authorize the board to fix directors’ remuneration. Additionally, a resolution will be proposed to allow the company to buy back up to 10% of its issued shares, which could impact shareholder value and market perception.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is a company incorporated in Hong Kong, operating within the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products and services, catering to a wide market in the healthcare sector.
YTD Price Performance: -19.26%
Average Trading Volume: 1,550
Technical Sentiment Signal: Buy
Current Market Cap: €3.5B
See more insights into 3320 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue